LITHISTID SPONGES DERIVED COMPOUNDS AND THEIR IMPORTANCE IN BIOLOGICAL RESEARCH - A REVIEW

Authors

  • Abirla M Department of Bio-Engineering, School of Engineering, Vels Institute of Science, Technology and Advanced Studies (VISTAS), Chennai, Tamil Nadu, India.
  • Brindha Devi P Department of Bio-Engineering, School of Engineering, Vels Institute of Science, Technology and Advanced Studies (VISTAS), Chennai, Tamil Nadu, India.

DOI:

https://doi.org/10.22159/ajpcr.2018.v11i6.24937

Keywords:

Lithistid sponges, Biological compounds, Anti-fungal activity, Anti-HIV activity

Abstract

Lithistid sponges have an important source of complex natural compounds with biological activities. The lithistid sponges are of interest to biomedical science because of the great variety of pharmaceutically relevant biological activities of their chemical extracts and are considered as economically important. The compounds identified in these sponges have therapeutic potential and have been frequently hypothesized to contain compounds of bacterial origin. The peptides identified from these lithistid sponges are found to be the sources of antifungal activity. The active agents of these sponges also have cytotoxic and immunosuppressive activities. Many of the cyclic peptides of lithistid represent the anti-HIV activity. The different structure and biological activities of the compounds derived from these sponges have more chemical aspects too.

Downloads

Download data is not yet available.

Author Biographies

Abirla M, Department of Bio-Engineering, School of Engineering, Vels Institute of Science, Technology and Advanced Studies (VISTAS), Chennai, Tamil Nadu, India.

Department of Bio-Engineering

Brindha Devi P, Department of Bio-Engineering, School of Engineering, Vels Institute of Science, Technology and Advanced Studies (VISTAS), Chennai, Tamil Nadu, India.

Department of Bio-Engineering

References

Bewley D, Carole A, Faulkner DJ. Lithistid sponges: Star performers or hosts to the stars. Angew Chem Int Ed 1998;37:2162-78.

Bewley CA, Debitus C, Faulkner DJ. Microsclerodermins A and B. Antifungal cyclic peptides from the lithistid sponge Microscleroderma sp. J Am Chem Soc 1994;116:7631-6.

Pomponi SA, Kelly M, Reed JK, Wright AE. Diversity and bathymetric distribution of lithistid sponges in the tropical western Atlantic region. Proc Biol Soc Washington 2001;10:344-53.

Schmidt EW, Obraztsova AY, Davidson SK, Faulkner DJ, Haygood MG. Identification of the antifungal peptide-containing symbiont of the marine sponge Theonella swinhoei as a novel δ-proteobacterium, Candidatus Entotheonella palauensisâ€. Mar Biol 2000;136:969-77.

Guy MN, Dixon OA. Upper silurian lithistid sponge reefs on Somerset Island, arctic Canada. Sedimentology 1984;31:25-50.

Wright AE. The Lithistida: Important sources of compounds useful in biomedical research. Curr Opin Biotechnol 2010;21:801-7.

Zheng LH, Wang YJ, Sheng J, Wang F, Zheng Y, Lin XK, et al. Antitumor peptides from marine organisms. Mar Drugs 2011;9:1840-59.

Theonellamide F. A novel antifungal bicyclic peptide from a marine sponge Theonella sp. Matsunaga, Shigeki; Fusetani, Nobuhiro; Hashimoto, Kanehisa; Walchli. J Am Chem Soc 1989;111:2582-8.

Youssef DT, Shaala LA, Mohamed GA, Badr JM, Bamanie FH, Ibrahim SR, et al. Theonellamide G, a potent antifungal and cytotoxic bicyclic glycopeptide from the red sea marine sponge Theonella swinhoei. Mar Drugs 2014;12:1911-23.

Faulkner DJ, Harper MK, Haygood MG, Salomon CE, Schmidt EW. Symbiotic bacteria in sponges: Sources of bioactive substances. In Drugs from the Sea. Basel, Switzerland: Karger Publishers; 2000. p. 107-19.

Müller WE, Grebenjuk VA, Le Pennec G, Schröder H, Brümmer F, Hentschel U, et al. Sustainable production of bioactive compounds by sponges--cell culture and gene cluster approach: A review. Mar Biotechnol (NY) 2004;6:105-17.

Ho CH, Magtanong L, Barker SL, Gresham D, Nishimura S, Natarajan P, et al. A molecular barcoded yeast ORF library enables mode-of-action analysis of bioactive compounds. Nat Biotechnol 2009;27:369-77.

Haygood MG, Schmidt EW, Davidson SK, Faulkner DJ. Microbial symbionts of marine invertebrates: Opportunities for microbial biotechnology. J Mol Microbiol Biotechnol 1999;1:33-43.

Hill RT. Microbes from marine sponges: A treasure trove of biodiversity for natural products discovery. In: Microbial Diversity and Bioprospecting. Washington DC: American Society of Microbiology; 2004. p. 177-90.

Ratnayake AS, Bugni TS, Feng X, Harper MK, Skalicky JJ, Mohammed KA, et al. Theopapuamide: A cyclic depsipeptide from a Papua New Guinea lithistid sponge Theonella swinhoei. J Nat Prod 2006;69:1582.

Festa C, De Marino S, Sepe V, Monti MC, Luciano P, D’Auria MV, et al. Perthamides C and D, two new potent anti-inflammatory cyclopeptides from a Solomon Lithistid sponge Theonella swinhoei. Tetrahedron 2009;65:10424-9.

Valeria DM, Zampella A, Zollo F. The chemistry of lithistid sponge: A spectacular source of new metabolites. Stud Nat Prod Chem 2002;26:1175-258.

Theonellamide F. A bicyclic peptide marine toxin, induces formation of vacuoles in 3Y1 rat embryonic fibroblast Wada, Shun-Ichi; Matsunaga, Shigeki; Fusetani, Nobuhiro; Watabe, Shugo. Mar Biotechnol 1999;1:337-41.

Winder, Priscilla L, Pomponi SA, Amy E. Wright. Natural Products from the Lithistida: A Review of the Literature since 2000. Marine drugs 9.12 (2011): 2643-82.

De Marino S, Festa C, D’Auria MV, Cresteil T, Debitus C, Zampella A, et al. Swinholide J, a potent cytotoxin from the marine sponge Theonella swinhoei. Mar Drugs 2011;9:1133-41.

Costantino V, Fattorusso E, Imperatore C, Mangoni A. Glycolipids from sponges. 11. 1 isocrasserides, novel glycolipids with a five-membered cyclitol widely distributed in marine sponges. J Nat Prod 2002;65:883-6.

Plaza A, Gustchina E, Baker HL, Kelly M, Bewley CA. Mirabamides A-D, depsipeptides from the sponge Siliquariaspongia mirabilis that inhibit HIV-1 fusion. J Nat Prod 2007;70:1753-60.

Raskin I, Ribnicky DM, Komarnytsky S, Ilic N, Poulev A, Borisjuk N, et al. Plants and human health in the twenty-first century. Trends Biotechnol 2002;20:522-31.

Ibañez E, Herrero M, Mendiola JA, Castro-Puyana M. Extraction and characterization of bioactive compounds with health benefits from marine resources: Macro and micro algae, Cyanobacteria, and Invertebrates. In: Marine Bioactive Compounds. Boston, MA: Springer; 2012. p. 55-98.

Hamed I, Özogul F, Özogul Y, Regenstein JM. Marine bioactive compounds and their health benefits: A review. Compr Rev Food Sci Food Saf 2015;14:446-65.

Paterson I, Dalby SM, Roberts JC, Naylor GJ, Guzmán EA, Isbrucker R, et al. Leiodermatolide, a potent antimitotic macrolide from the marine sponge Leiodermatium sp. Angew Chem Int Ed 2011;50:3219-23.

Fagerholm AE, Habrant D, Koskinen AM. 2010. Calyculins and related marine natural products as serine-threonine protein phosphatase PP1 and PP2A inhibitors and total syntheses of calyculin A, B, and C. Marine drugs, 8;1:122-172.

Kumar JR, Zi-Rong X. Biomedical compounds from marine organisms. Mar Drugs 2004;2:123-46.

Narbonne GM, Dixon OA. Upper Silurian lithistid sponge reefs on Somerset Island, arctic Canada. Sedimentology 1984;31:25-50.

Eric WS, Raventos-Suarez C, Bifano M, Menendez AT, Fairchild CR, Faulkner DJ. Scleritodermin A, a cytotoxic cyclic peptide from the lithistid sponge Scleritoderma nodosum. J Nat Prod 2004;67:475-8.

Hu GP, Yuan J, Sun L, She ZG, Wu JH, Lan XJ, et al. Statistical research on marine natural products based on data obtained between 1985 and 2008. Mar Drugs 2011;9:514-25.

Ana M, Vieira H, Gaspar H, Santos S. Marketed marine natural products in the pharmaceutical and cosmeceutical industries: Tips for success. Mar Drugs 2014;12:1066-101.

Rana M, Luesch H. Marine natural products: A new wave of drugs? Future Med Chem 2011;3:1475-89.

Ebaa ME, Cheng C, Hamed MM, El-Sayed Hamed AN, Ohlsen K, Hentschel U, Abdelmohsen UR. Antifungal potential of marine natural products. Eur J Med Chem 2017;126:631-51.

Nelson GM, Dasari R, Chandra S, Kiss R, Kornienko A. Marine invertebrate metabolites with anticancer activities: Solutions to the supply problemâ€. Mar Drugs 2016;14:98.

Zampella A, D’Auria MV, Minale L, Debitus C, Roussakis C. Callipeltoside A: A cytotoxic aminodeoxy sugar-containing macrolide of a new type from the marine Lithistida sponge Callipelta sp. J Am Chem Soc 1996;118:11085-8.

Bergquist, Patricia R. Sponges. Berkeley: Univ of California Press; 1978.

Michael WT, Radax R, Steger D, Wagner M. Sponge-associated microorganisms: Evolution, ecology, and biotechnological potential. Microbiol Mol Biol Rev 2007;71: 295-347.

Vedanjali G, Schinazi RF, Hamann MT. Role of marine natural products in the genesis of antiviral agents. Chem Rev 2015;115:9655-706.

Danielle S, Wei L. Recent advances in deep-sea natural products. Nat Prod Reports 2014;31:999-1025.

Christine M, Cárdenas P. Proposal for a revised classification of the Demospongiae (Porifera). Front Zool 2015;12:7.

Hanna Lydia SC. Happy relationships between marine sponges and sediments-a review and some observations from Australia. J Mar Biol Assoc U K 2016;96:493-514.

Cárdenas P, Rapp HT. Demosponges from the northern mid-Atlantic ridge shed more light on the diversity and biogeography of North Atlantic deep-sea sponges. J Mar Biol Assoc U K 2015;95:1475-516.

John WC. Chemistry Under the Sea: Secondary Metabolites from Marine Sponges of Papua New Guinea. Santa Cruz: University of California; 2007.

Pisera A, Lévi C. ‘Lithistid’ Demospongiae. In: Systema porifera. Boston, MA: Springer; 2002. p. 299-301.

Wörheide G, Dohrmann M, Erpenbeck D, Larroux C, Maldonado M,Voigt O, et al. Deep phylogeny and evolution of sponges (Phylum Porifera). In: Advances in Marine Biology. Vol. 61. The Netherlands: Academic Press; 2012. p. 1-78.

Gochfeld DJ, El Sayed KA, Yousaf M, Hu J, Bartyzel P, Dunbar DC, Wilkins SP, et al. Marine natural products as lead anti-HIV agents. Mini Rev Med Chem 2003;3:401-24.

Thomas TR, Kavlekar DP, Bharathi PA. Marine drugs from sponge-microbe association-A review. Mar Drugs 2010;8:1417-68.

David JN, Cragg M. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod 2012;75:311-35.

Felix W. Zoogeographyâ€. In: Shallow-Water Sponges of the Western Bahamas. Basel: Birkhäuser; 1977. p. 239-48.

Michelle K. Porifera: Lithistid Demospongiae (rock Sponges). Wellington: National Institute of Water and Atmospheric Research (NIWA); 2007.

Michelle KB, Pomponi SA. Phylogeny and classification of lithistid sponges (Porifera: Demospongiae): A preliminary assessment using ribosomal DNA sequence comparisons. Mol Mar Biol Biotechnol 1994;3:87-103.

Pisera A, Vacelet J. Lithistid sponges from submarine caves in the Mediterranean: Taxonomy and affinities. Sci Mar 2010;75:17-40.

Nishimura S, Arita Y, Honda M, Iwamoto K, Matsuyama A, Shirai A, et al. Marine antifungal Theonella mides target 3β-hydroxysterol to activate Rho1 signaling. Nat Chem Biol 2010;6:519.

Paterson I, Naylor GJ, Fujita T, Guzmán E, Wright AE. Total synthesis of a library of designed hybrids of the microtubule-stabilising anticancer agents taxol, discodermolide and dictyostatin. Chem Commun 2010;46:261-3.

Julie LE, Bai L, Jung WH, Moura-Letts G, Day BW, Curran DP. Improved synthesis of 6-epi-dictyostatin and antitumor efficacy in mice bearing MDA-MB231 human breast cancer xenografts. J Med Chem 2008;51:6650-3.

Isbrucker RA, Cummins J, Pomponi SA, Longley RE, Wright AE. Tubulin polymerizing activity of dictyostatin-1, a polyketide of marine sponge origin. Biochem Pharmacol 2003;66:75-82.

Canales A, Matesanz R, Gardner NM, Andreu JM, Paterson I, Díaz JF, et al. The bound conformation of microtubule-stabilizing agents: NMR insights into the bioactive 3D structure of discodermolide and dictyostatin. Chem A Eur J 2008;14:7557-69.

Cynthia DA, Planelles V, Barrows LR. Characterizing the anti-HIV activity of papuamide A. Mar Drugs 2008;6:528-49.

Ernst TH, Kowalski RJ, Hamel E, Lin CM, Longley RE, Gunasekera SP, et al. Discodermolide, a cytotoxic marine agent that stabilizes microtubules more potently than taxol. Biochem 1996;35:243-50.

Hei HC, Magtanong L, Barker SL, Gresham D, Nishimura S, Natarajan P, et al. A molecular barcoded yeast ORF library enables mode-of-action analysis of bioactive compounds. Nat Biotechnol 2009;27:369.

Ishihara H, Martin BL, Brautigan DL, Karaki H, Ozaki H, Kato Y, et al. Calyculin A and okadaic acid: Inhibitors of protein phosphatase activity. Biochem Biophys Res Commun 1989;159:871-7.

Jörn P, Butzke D, Fusetani N, Hui D, Platzer M, Wen G, et al. Exploring the chemistry of uncultivated bacterial symbionts: Antitumor polyketides of the pederin family. J Nat Prod 2005;68:472-9.

Carvalho FC, Pomponi SA, Xavier JR. Lithistid sponges of the upper bathyal of Madeira, Selvagens and Canary Islands, with description of a new species of Isabella. J Mar Biol Assoc U K 2015;95:1287-96.

Wolfram MB, Reed JK, McCarthy PJ. The bacterial community of the lithistid sponge Discodermia spp. as determined by cultivation and culture-independent methods. Mar Biotechnol 2012;14:762-73.

Andrzej P, Pomponi SA. New data on lithistid sponges from the deep Florida shelf with description of a new species of Theonella. J Mar Biol Assoc U K 2015;95:1297-309.

Madhu V, Sivaperumal P, Kamal AK, Ambekar AA, Kulkarni BG. Antibacterial and antioxidant activities of the tissue extract of Perna Viridis Linnaeus, 1758 (Mollusca: Bivalvia) From Versova Coast, Mumbai. Int J Pharm Pharm Sci 2014;6:704-7.

Praveena T, Fathima SK. Anticancer activity of protein extract from Perna viridis (Green Mussel) and Meretrix meretrix (Great Clam). Int J Pharm Pharm Sci 2017;6:1161-6.

Published

07-06-2018

How to Cite

M, A., and B. Devi P. “LITHISTID SPONGES DERIVED COMPOUNDS AND THEIR IMPORTANCE IN BIOLOGICAL RESEARCH - A REVIEW”. Asian Journal of Pharmaceutical and Clinical Research, vol. 11, no. 6, June 2018, pp. 57-60 Article Retracted, doi:10.22159/ajpcr.2018.v11i6.24937.

Issue

Section

Review Article(s)